share_log
Benzinga ·  May 7 07:12
Zentalis Pharma's Q1 Cash, Cash Equivalents and Marketable Securities Position Of $489M Is Expected To Provide Cash Runway Into Mid-2026
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment